Drugs / MB097
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06540391 | Aug 2024 → Dec 2025 overdue | melanoma | Microbiotica Ltd | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MB097 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06540391 ↗ |
| Modality | Other / unclassified | “Live bacterial therapeutic for oral administration” NCT06540391 ↗ |
| Route | Oral | “Live bacterial therapeutic for oral administration” NCT06540391 ↗ |